The ACE DD genotype and D-allele are associated with exceptional longevity: A meta-analysis

Ageing Research Reviews

Volumn 12, Issue 4, 2013, Pages 1079-1087

  Garatachea, Nuria ^a   Marín, Pedro J ^b,c   Lucia, Alejandro ^d,e  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b EUROPEAN UNIVERSITY MIGUEL DE CERVANTES   (Spain)

^c Research Center on Physical Disability   (Spain)

^d UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^e Instituto de Investigación Hospital 12 de Octubre i 12   (Spain)

Author keywords

ACE gene; Centenarians; Genetics

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; BIBLIOGRAPHIC DATABASE; CAUCASIAN; CHI SQUARE TEST; CHINESE; EMBASE; ETHNIC GROUP; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INHERITANCE; LONGEVITY; MEDLINE; META ANALYSIS (TOPIC); POPULATION GENETICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ACE GENE; CENTENARIANS; GENETICS;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HUMANS; LONGEVITY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 84888198358     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2013.04.001     Document Type: Review

References (53)

1. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 2006, 6:50.
2. Bladbjerg E.M., Andersen-Ranberg K., de Maat M.P., Kristensen S.R., Jeune B., Gram J., Jespersen J. Longevity is independent of common variations in genes associated with cardiovascular risk. Thrombosis and Haemostasis 1999, 82:1100-1105.
3. Blanche H., Cabanne L., Sahbatou M., Thomas G. A study of French centenarians: are ACE and APOE associated with longevity?. Comptes Rendus de l'Academie des Sciences. Serie III, Sciences de la Vie 2001, 324:129-135.
4. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
5. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nature Reviews Genetics 2001, 2:91-99.
6. Costerousse O., Allegrini J., Lopez M., Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochemical Journal 1993, 290(Pt 1):33-40.
7. Costerousse O., Jaspard E., Wei L., Corvol P., Alhenc-Gelas F. The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans. Journal of Cardiovascular Pharmacology 1992, 20(Suppl. 9):S10-S15.
8. Crisan D., Carr J. Angiotensin I-converting enzyme: genotype and disease associations. Journal of Molecular Diagnostics 2000, 2:105-115.
9. Choi Y.H., Kim J.H., Kim D.K., Kim J.W., Kim D.K., Lee M.S., Kim C.H., Park S.C. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences 2003, 58:227-231.
10. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
11. de Cavanagh E.M., Inserra F., Ferder L. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?. Cardiovascular Research 2011, 89:31-40.
12. Dikmen M., Gunes H.V., Degirmenci I., Ozdemir G., Basaran A. Are the angiotensin-converting enzyme gene and activity risk factors for stroke?. Arquivos de Neuro-psiquiatria 2006, 64:211-216.
13. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
14. Ehlers M.R., Riordan J.F. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989, 28:5311-5318.
15. Eisenlohr L.C., Bacik I., Bennink J.R., Bernstein K., Yewdell J.W. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell 1992, 71:963-972.
16. Faure-Delanef L., Baudin B., Beneteau-Burnat B., Beaudoin J.C., Giboudeau J., Cohen D. Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clinical Chemistry 1998, 44:2083-2087.
17. Fiuza-Luces C., Ruiz J.R., Rodriguez-Romo G., Santiago C., Gomez-Gallego F., Cano-Nieto A., Garatachea N., Rodriguez-Moreno I., Moran M., Lucia A. Is the ACE I/D polymorphism associated with extreme longevity? A study on a Spanish cohort. Journal of the Renin-Angiotensin-Aldosterone System 2011, 12:202-207.
18. Galinsky D., Tysoe C., Brayne C.E., Easton D.F., Huppert F.A., Dening T.R., Paykel E.S., Rubinsztein D.C. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997, 129:177-183.
19. Garatachea N., Lucia A. Genes, physical fitness and ageing. Ageing Research Reviews 2013, 12:90-102.
20. Hu J., Igarashi A., Kamata M., Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. Journal of Biological Chemistry 2001, 276:47863-47868.
21. Huang S., Chen X.H., Payne J.R., Pennell D.J., Gohlke P., Smith M.J., Day I.N., Montgomery H.E., Gaunt T.R. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics. Pharmacogenetics and Genomics 2007, 17:291-294.
22. Kehoe P.G., Russ C., McIlory S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B., Liddell M., Plomin R., Dynan K., Williams N., Neal J., Cairns N.J., Wilcock G., Passmore P., Lovestone S., Williams J., Owen M.J. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nature Genetics 1999, 21:71-72.
23. Lewis S.J., Brunner E.J. Methodological problems in genetic association studies of longevity-the apolipoprotein E gene as an example. International Journal of Epidemiology 2004, 33:962-970.
24. Li X., Li Y., Jia N., Guo S., Chu S., Niu W. Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis. Molecular Biology Reports 2012, 39:10063-10075.
25. Li Y. Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants. Internal Medicine Journal 2012, 42:439-444.
26. Malik F.S., Lavie C.J., Mehra M.R., Milani R.V., Re R.N. Renin-angiotensin system: genes to bedside. American Heart Journal 1997, 134:514-526.
27. Martin G.M., Bergman A., Barzilai N. Genetic determinants of human health span and life span: progress and new opportunities. PLOS Genetics 2007, 3:e125.
28. Metter E.J., Talbot L.A., Schrager M., Conwit R.A. Arm-cranking muscle power and arm isometric muscle strength are independent predictors of all-cause mortality in men. Journal of Applied Physiology 2004, 96:814-821.
29. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Brynes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., Humphries S.E. Human gene for physical performance. Nature 1998, 393:221-222.
30. Nacmias B., Bagnoli S., Tedde A., Cellini E., Bessi V., Guarnieri B., Ortensi L., Piacentini S., Bracco L., Sorbi S. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity. Archives of Gerontology and Geriatrics 2007, 45:201-206.
31. Panza F., Solfrizzi V., D'Introno A., Capurso C., Basile A.M., Colaiccco A.M., Sabba M., Noya R., Capurso A. Apolipoprotein and antiotensin converting enzyme genes: regional differences and extreme longevity in Europe. Archives of Gerontology and Geriatrics Supplement 2002, 8:247-251.
32. Panza F., Solfrizzi V., D'Introno A., Colacicco A.M., Capurso C., Kehoe P.G., Capurso A. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Experimental Gerontology 2003, 38:1015-1020.
33. Paolisso G., Tagliamonte M.R., De Lucia D., Palmieri F., Manzella D., Rinaldi C., Bossone A., Colaizzo D., Margaglione M., Varricchio M. ACE gene polymorphism and insulin action in older subjects and healthy centenarians. Journal of the American Geriatrics Society 2001, 49:610-614.
34. Philipp C.S., Dilley A., Saidi P., Evatt B., Austin H., Zawadsky J., Harwood D., Ellingsen D., Barnhart E., Phillips D.J., Hooper W.C. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thrombosis and Haemostasis 1998, 80:869-873.
35. Puthucheary Z., Skipworth J.R., Rawal J., Loosemore M., Van Someren K., Montgomery H.E. The ACE gene and human performance: 12 years on. Sports Medicine 2011, 41:433-448.
36. Rahmutula D., Nakayama T., Izumi Y., Ozawa Y., Shimabukuro H., Kawamura H., Zhen-Wang S., Xiong-Wang J., Aisa M., Run-Yang C., Mahmut M., Mahsut R., Hen-Chen Z. Angiotensin-converting enzyme gene and longevity in the Xin Jiang Uighur autonomous region of China: an association study. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002, 57:M57-M60.
37. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 1990, 86:1343-1346.
38. Robine J.M., Paccaud F. Nonagenarians and centenarians in Switzerland, 1860-2001: a demographic analysis. Journal of Epidemiology and Community Health 2005, 59:31-37.
39. Ruiz J.R., Sui X., Lobelo F., Morrow J.R., Jackson A.W., Sjostrom M., Blair S.N. Association between muscular strength and mortality in men: prospective cohort study. British Medical Journal 2008, 337:a439.
40. Schachter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nature Genetics 1994, 6:29-32.
41. Seripa D., Franceschi M., Matera M.G., Panza F., Kehoe P.G., Gravina C., Orsitto G., Solfrizzi V., Di Minno G., Dallapiccola B., Pilotto A. Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2006, 61:918-923.
42. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association 2000, 283:2008-2012.
43. Szumilas M. Explaining odds ratios. Journal of the Canadian Academy of Child and Adolescent Psychiatry 2010, 19:227-229.
44. Tao H.M., Shao B., Chen G.Z. Meta-analysis of the ACE gene polymorphism in cerebral infarction. Canadian Journal of Neurological Sciences 2009, 36:20-25.
45. Vaisi-Raygani A., Ghaneialvar H., Rahimi Z., Nomani H., Saidi M., Bahrehmand F., Vaisi-Raygani A., Tavilani H., Pourmotabbed T. The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clinical Biochemistry 2010, 43:1189-1194.
46. Williams A.G., Day S.H., Folland J.P., Gohlke P., Dhamrait S., Montgomery H.E. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Medicine and Science in Sports and Exercise 2005, 37:944-948.
47. Woods D., Hickman M., Jamshidi Y., Brull D., Vassiliou V., Jones A., Humphries S., Montgomery H. Elite swimmers and the D allele of the ACE I/D polymorphism. Human Genetics 2001, 108:230-232.
48. Wufuer M., Fang M.W., Cheng Z.H., Qiu C.C. Polymorphism of angiotensin converting enzyme gene and natural longevity in the Xinjiang Uygur people: an association study. Zhonghua yi xue za zhi 2004, 84:1603-1606.
49. Xi B., Ruiter R., Chen J., Pan H., Wang Y., Mi J. The ACE insertion/deletion polymorphism and its association with metabolic syndrome. Metabolism: Clinical and Experimental 2012, 61:891-897.
50. Yang J.K., Gong Y.Y., Xie L., Lian S.G., Yang J., Xu L.Y., Gao S.J., Zhang Y.P. Lack of genetic association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and longevity in a Han Chinese population. Journal of the Renin-Angiotensin-Aldosterone System 2009, 10:115-118.
51. Zajc Petranovic M., Skaric-Juric T., Smolej Narancic N., Tomas Z., Krajacic P., Milicic J., Barbalic M., Tomek-Roksandic S. Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans. Age 2012, 34:583-595.
52. Zhang Z., Xu G., Liu D., Fan X., Zhu W., Liu X. Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies. PLoS ONE 2012, 7:e46495.
53. Zintzaras E., Raman G., Kitsios G., Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Archives of Internal Medicine 2008, 168:1077-1089.